Skip to main content
. 2023 Mar 15;130:196–202. doi: 10.1016/j.ijid.2023.03.017

Table 1.

Baseline characteristics and pregnancy outcomes in participants excluding those of losing follow-up or artificial abortion in early pregnancy.

Characteristic Vaccinated group (165) % No-vaccination group (717) % P-value
Age, mean (SD),y
<35 137/165 594/717
≥35 28/165 16.97 123/717 17.15 0.955
Body mass index (kg/m2)
Normal (<24 kg/m2) 139/165 613/717
Overweight (≥24 kg/m2) 26/165 15.76 104/717 14.50 0.682
Previous miscarriage 21/165 12.73 122/717 17.02 0.178
Twin pregnancy 1/165 0.61 3/717 0.42 0.746
Uterine anatomy 1/165 0.61 3/717 0.42 0.746
Nulliparous 119/165 72.12 590/717 82.29 0.003
Pregnancy loss
Miscarriage 20/165 12.12 89/717 12.41 0.918
Stillbirth 1/119 0
Neonatal death 0 0
Birth defect 1/120 0.83 5/514 1.00 0.887
Congenital anomalies 1 2
Chromosome abnormality 0 3

The denominator of the birth defect rate in the vaccination group included live-born infants. A total of 119 women in the study group delivered their babies, including one twin, during the study period. One case of congenital anomaly, i.e., atrial septal defect, was recorded in the vaccinated group, and the baby was still alive.

The denominator of the birth defect rate in the nonvaccinated group included live-born infants, and 511 women delivered their babies, including three twins, during the study period. Three cases of chromosomal abnormalities in the nonvaccinated group included two cases of trisomy 21 and one case of Noonan syndrome, which were manually terminated. Two cases of congenital malformations in the nonvaccinated group included one case of loss of the corpus callosum and one case of a solid mass in the right abdomen of the fetus, which were also manually terminated.

The denominator of stillbirth in the vaccination group was the number of live birth.